Provider Effects in Antibiotic Prescribing

References

1. ↵
   1. Abaluck, Jason,
   2. Leila Agha,
   3. David Chan,
   4. Daniel E. Singer, and
   5. Diana Zhu

   . 2022. “Fixing Misallocation with Guidelines: Awareness vs. Adherence.” Working paper.
2. ↵
   1. Abaluck, Jason,
   2. Leila Agha,
   3. Chris Kabrhel,
   4. Ali Raja, and
   5. Arjun Venkatesh

   . 2016. “The Determinants of Productivity in Medical Testing: Intensity and Allocation of Care.” American Economic Review 106(12):3730–64.

   OpenUrlCrossRef
3. ↵
   1. Adda, Jérôme.

   2020. “Preventing the Spread of Antibiotic Resistance.” AEA Papers and Proceedings 110:255–59.

   OpenUrl
4. ↵
   1. Agarwal, Nikhil,
   2. Alex Moehring,
   3. Pranav Rajpurkar, and
   4. Tobias Salz

   . 2023. “Combining Human Expertise with Artificial Intelligence: Experimental Evidence from Radiology.” NBER Working Paper w31422. Cambridge, MA: NBER.
5. 1. Agha, Leila,
   2. Keith M. Ericson,
   3. Kimberly H. Geissler, and
   4. James B. Rebitzer

   . 2022. “Team Relationships and Performance: Evidence from Healthcare Referral Networks.” Management Science 68(5):3735–754.

   OpenUrlCrossRef
6. ↵
   1. Agha, Leila,
   2. Jonathan Skinner, and
   3. David Chan

   . 2022. “Improving Efficiency in Medical Diagnosis.” JAMA 327(22):2189–190.

   OpenUrlPubMed
7. ↵
   1. Belloni, Alexandre, and
   2. Victor Chernozhukov

   . 2013. “Least Squares after Model Selection in High-Dimensional Sparse Models.” Bernoulli 19(2):521–47.

   OpenUrl
8. ↵
   1. Bennett, Daniel,
   2. Che-Lun Hung, and
   3. Tsai-Ling Lauderdale

   . 2015. “Health Care Competition and Antibiotic Use in Taiwan.” Journal of Industrial Economics 63(2):371–93.

   OpenUrlCrossRef
9. ↵
   1. Chan, David C.

   2021. “Influence and Information in Team Decisions: Evidence from Medical Residency.” American Economic Journal: Economic Policy 13(1):106–37.

   OpenUrl
10. ↵
    1. Chan, David C.,
    2. Matthew Gentzkow, and
    3. Chuan Yu

    . 2022. “Selection with Variation in Diagnostic Skill: Evidence from Radiologists.” Quarterly Journal of Economics 137(2):729–83.

    OpenUrlPubMed
11. ↵
    1. Chandra, Amitabh, and
    2. Douglas O. Staiger

    . 2007. “Productivity Spillovers in Health Care: Evidence from the Treatment of Heart Attacks.” Journal of Political Economy 115(1):103–40.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Coenen, Samuel,
    2. Matus Ferech,
    3. Flora M. Haaijer-Ruskamp,
    4. Chris C. Butler,
    5. Robert H. Vander Stichele,
    6. Theo J.M. Verheij,
    7. Dominique L. Monnet,
    8. Paul Little, and
    9. Herman Goossens

    . 2007. “European Surveillance of Antimicrobial Consumption (ESAC):Quality indicators for outpatient antibiotic use in Europe.” BMJ Quality & Safety 16(6):440–45.

    OpenUrlAbstract/FREE Full Text
13. ↵
    1. Costelloe, Céire,
    2. Chris Metcalfe,
    3. Andrew Lovering,
    4. David Mant, and
    5. Alastair D. Hay

    . 2010. “Effect of Antibiotic Prescribing in Primary Care on Antimicrobial Resistance in Individual Patients: Systematic Review and Meta-Analysis.” BMJ 340:c2096.

    OpenUrlAbstract/FREE Full Text
14. ↵
    1. Cuddy, Emily, and
    2. Janet Currie

    . 2026. “Rules Versus Discretion: Treatment of Mental Illness in US Adolescents.” Journal of Political Economy 134(1):478–522.

    OpenUrl
15. ↵
    1. Currie, Janet,
    2. Wanchuan Lin, and
    3. Juanjuan Meng

    . 2014. “Addressing Antibiotic Abuse in China: An Experimental Audit Study.” Journal of Development Economics 110:39–51.

    OpenUrlCrossRefPubMed
16. ↵
    1. Currie, Janet, and
    2. W. Bentley MacLeod

    . 2020. “Understanding Doctor Decision Making: The Case of Depression Treatment.” Econometrica 88(3):847–78.

    OpenUrlCrossRefPubMed
17. ↵
    1. Currie, Janet,
    2. W. Bentley MacLeod, and
    3. Jessica Van Parys

    . 2016. “Provider Practice Style and Patient Health Outcomes: The Case of Heart Attacks.” Journal of Health Economics 47:64–80.

    OpenUrlCrossRefPubMed
18. ↵
    1. Cutler, David,
    2. Jonathan S. Skinner,
    3. Ariel D. Stern, and
    4. David Wennberg

    . 2019. “Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending.” American Economic Journal: Economic Policy 11(1):192–221.

    OpenUrlCrossRefPubMed
19. ↵
    1. Doyle, Joseph J.,
    2. Steven M. Ewer, and
    3. Todd H. Wagner

    . 2010. “Returns to Physician Human Capital: Evidence from Patients Randomized to Physician Teams.” Journal of Health Economics 29(6):866–82.

    OpenUrlPubMed
20. ECDC, EFSA Panel on Biological Hazards (BIOHAZ) and EMA Committee for Medicinal Products for Veterinary Use (CVMP). 2017. “ECDC, EFSA and EMA Joint Scientific Opinion on a List of Outcome Indicators as Regards Surveillance of Antimicrobial Resistance and Antimicrobial Consumption in Humans and Food-Producing Animals.” EFSA Journal 15(10):05017.

    OpenUrl
21. ↵
    1. Ellegård, Lina M.,
    2. Jens Dietrichson, and
    3. Anders Anell

    . 2018. “Can Pay-for-Performance to Primary Care Providers Stimulate Appropriate Use of Antibiotics?” Health Economics 27(1):e39–e54.

    OpenUrlPubMed
22. ↵
    1. Epstein, Andrew J., and
    2. Sean Nicholson

    . 2009. “The Formation and Evolution of Physician Treatment Styles: An Application to Cesarean Sections.” Journal of Health Economics 28(6):1126–140.

    OpenUrlCrossRefPubMedWeb of Science
23. 1. Fadlon, Itzik,
    2. Frederik Plesner Lyngse, and
    3. Torben Heien Nielsen

    . 2024. “Early Career Setbacks and Women’s Career-Family Trade-Off.” NBER Working Paper w28245. Cambridge, MA: NBER.
24. ↵
    1. Fadlon, Itzik, and
    2. Jessica Van Parys

    . 2020. “Primary Care Physician Practice Styles and Patient Care: Evidence from Physician Exits in Medicare.” Journal of Health Economics 71:102304.

    OpenUrlPubMed
25. ↵
    1. Finkelstein, Amy,
    2. Matthew Gentzkow, and
    3. Dean Li

    . 2025. “What Drives Risky Prescription Opioid Use? Evidence From Migration” Quarterly Journal of Economics 140(4):3133–89.

    OpenUrlPubMed
26. ↵
    1. Finkelstein, Amy,
    2. Matthew Gentzkow, and
    3. Heidi Williams

    . 2016. “Sources of Geographic Variation in Health Care: Evidence from Patient Migration.” Quarterly Journal of Economics 131(4):1681–726.

    OpenUrlCrossRefPubMed
27. ↵
    1. Fleming-Dutra, Katherine E.,
    2. Adam L. Hersh,
    3. Daniel J. Shapiro,
    4. Monina Bartoces,
    5. Eva A. Enns,
    6. Thomas M. File,
    7. Jonathan A. Finkelstein,
    8. Jeffrey S. Gerber,
    9. David Y. Hyun,
    10. Jeffrey A. Linder, et al.

    2016. “Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits 2010–2011.” JAMA 315(17):1864–873.

    OpenUrlCrossRefPubMed
28. ↵
    1. Godøy, Anna, and
    2. Ingrid Huitfeldt

    . 2020. “Regional Variation in Health Care Utilization and Mortality.” Journal of Health Economics 71:102254.

    OpenUrlPubMed
29. ↵
    1. Goodman-Bacon, Andrew.

    2021. “Difference-in-Differences with Variation in Treatment Timing.” Journal of Econometrics 225(2):254–77.

    OpenUrlCrossRef
30. ↵
    1. Gruber, Jonathan,
    2. Benjamin Handel,
    3. Samuel Kina, and
    4. Jonathan Kolstad

    . 2020. “Managing Intelligence: Skilled Experts and AI in Markets for Complex Products.” NBER Working Paper w27038. Cambridge, MA: NBER.
31. ↵
    1. Hallsworth, Michael,
    2. Tim Chadborn,
    3. Anna Sallis,
    4. Michael Sanders,
    5. Daniel Berry,
    6. Felix Greaves,
    7. Lara Clements, and
    8. Sally C. Davies

    . 2016. “Provision of Social Norm Feedback to High Prescribers of Antibiotics in General Practice: A Pragmatic National Randomised Controlled Trial.” Lancet 387(10029):1743–752.

    OpenUrlCrossRefPubMed
32. 1. Hammerum, Anette M.,
    2. Ole E. Heuer,
    3. Hanne-Dorthe Emborg,
    4. Line Bagger-Skjøt,
    5. Vibeke F. Jensen,
    6. Anne-Marie Rogues,
    7. Robert L. Skov,
    8. Yvonne Agersø,
    9. Christian T. Brandt,
    10. Anne Mette Seyfarth,
    11. Arno Müller,
    12. Karin Hovgaard,
    13. Justin Ajufo,
    14. Flemming Bager,
    15. Frank M. Aarestrup,
    16. Niels Frimodt-Møller,
    17. Henrik C. Wegener, and
    18. Dominique L. Monnet

    . 2007. “Danish Integrated Antimicrobial Resistance Monitoring and Research Program.” Emerging Infectious Diseases 13(11):1633–39.

    OpenUrlCrossRef
33. ↵
    1. Hull, Peter.

    2018. “Estimating Treatment Effects in Mover Designs.” Working Paper. arXiv:1804.06721.
34. ↵
    1. Kristiansen, Ida Lykke, and
    2. Sophie Yanying Sheng

    . 2025. “The Physician–Patient Match and Health Inequality.” Review of Economics and Statistics. Forthcoming.
35. ↵
    1. Laxminarayan, Ramanan.

    2022. “The Overlooked Pandemic of Antimicrobial Resistance.” Lancet 399(10325):P606–607.

    OpenUrl
36. ↵
    1. Laxminarayan, Ramanan, and
    2. Gardner M. Brown

    . 2001. “Economics of Antibiotic Resistance: A Theory of Optimal Use.” Journal of Environment Economics and Management 42(2):183–206.

    OpenUrl
37. ↵
    1. Manski, Charles F.

    2018. “Reasonable Patient Care under Uncertainty.” Health Economics 27(10):1397–421.

    OpenUrlPubMed
38. ↵
    1. Meeker, Daniella,
    2. Jeffrey A. Linder,
    3. Craig R. Fox,
    4. Mark W. Friedberg,
    5. Stephen D. Persell,
    6. Noah J. Goldstein,
    7. Tara K. Knight,
    8. Joel W. Hay, and
    9. Jason N. Doctor

    . 2016. “Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing among Primary Care Practices: A Randomized Clinical Trial.” JAMA 315(6):562–70.

    OpenUrlCrossRefPubMed
39. ↵
    1. Molitor, David.

    2018. “The Evolution of Physician Practice Styles: Evidence from Cardiologist Migration.” American Economic Journal: Economic Policy 10(1):326–56.

    OpenUrlCrossRefPubMed
40. ↵
    1. Pulcini, Céline,
    2. Freya Wencker,
    3. Niels Frimodt-Møller,
    4. Winfried V. Kern,
    5. Dilip Nathwani,
    6. Jesús Rodríguez-Baño,
    7. Gunnar Skov Simonsen,
    8. Vera Vlahović-Palčevski,
    9. Inge C. Gyssens

    , and ESGAP Curriculum Working Group. 2015. “European Survey on Principles of Prudent Antibiotic Prescribing Teaching in Undergraduate Students.” Clinical Microbiology and Infection 21(4):354–61.

    OpenUrlPubMed
41. 1. Ribers, Michael A., and
    2. Hannes Ullrich

    . 2023. “Machine Predictions and Human Decisions with Variation in Payoffs and Skill: The Case of Antibiotic Prescribing.” Berlin School of Economics Discussion Paper 27. Berlin: Berlin School of Economics.
42. ↵
    1. Ribers, Michael A., and
    2. Hannes Ullrich

    . 2024. “Complementarities Between Algorithmic and Human Decision-Making: The Case of Antibiotic Prescribing.” Quantitative Marketing and Economics 22(4):445–83.

    OpenUrl
43. ↵
    1. Salm, Martin, and
    2. Ansgar Wübker

    . 2020. “Sources of Regional Variation in Healthcare Utilization in Germany.” Journal of Health Economics 69:102271.

    OpenUrlPubMed
44. ↵
    1. Schnell, Molly, and
    2. Janet Currie

    . 2018. “Addressing the Opioid Epidemic: Is There a Role for Physician Education?” American Journal of Health Economics 4(3):383–410.

    OpenUrlCrossRefPubMed
45. ↵
    1. Simeonova, Emilia,
    2. Niels Skipper, and
    3. Peter Rønø Thingholm

    . 2024. “Physician Health Management Skills and Patient Outcomes.” Journal of Human Resources 59(3):777–809.

    OpenUrlFREE Full Text
46. ↵
    1. Simonsen, Marianne,
    2. Lars Skipper,
    3. Niels Skipper, and
    4. Peter R. Thingholm

    . 2021. “Discontinuity in Care: Practice Closures among Primary Care Providers and Patient Health Care Utilization.” Journal of Health Economics 80:102551.

    OpenUrlPubMed
47. ↵
    1. Sun, Liyang, and
    2. Sarah Abraham

    . 2021. “Estimating Dynamic Treatment Effects in Event Studies with Heterogeneous Treatment Effects.” Journal of Econometrics 225(2):175–99.

    OpenUrlCrossRef
48. ↵
    World Bank. 2017. “Drug-Resistant Infections: A Threat to Our Economic Future.” Washington, DC: World Bank.
49. ↵
    World Health Organization Regional Office for Europe. 2016. “Assessing Health Services Delivery Performance with Hospitalizations for Ambulatory Care Sensitive Conditions.” Working document. Copenhagen: WHO Regional Office for Europe.